Cite
HARVARD Citation
Kalil, A. et al. (2021). Efficacy of interferon beta-1a plus remdesivir compared with remdesivir alone in hospitalised adults with COVID-19: a double-blind, randomised, placebo-controlled, phase 3 trial. Lancet. 9 (12), pp. 1365-1376. [Online].